Louis Champel
Director/Board Member at VETOQUINOL SA
Profile
Louis Champel is an Independent Director at Vétoquinol SA since 2009.
Prior to this, he was the Chief Executive Officer at Rhone Merieux.
He also served as the Chairman & Chief Executive Officer at Merial SAS from 1997 to 2000.
From 2002 to 2008, he was the Managing Director at Lyon 3 Valorisation.
Mr. Champel completed his undergraduate degree at Sciences Po.
Louis Champel active positions
Companies | Position | Start |
---|---|---|
VETOQUINOL SA | Director/Board Member | 21/09/2010 |
Former positions of Louis Champel
Companies | Position | End |
---|---|---|
Lyon 3 Valorisation | Chief Executive Officer | 31/12/2007 |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Chief Executive Officer | 31/12/1999 |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Executive Officer | - |
Training of Louis Champel
Sciences Po | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VETOQUINOL SA | Health Technology |
Private companies | 3 |
---|---|
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Lyon 3 Valorisation |
- Stock Market
- Insiders
- Louis Champel